IDT Signs Contract to Supply Research Councils UK with Custom Oligonucleotides
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Integrated DNA Technologies (IDT) has signed a three year contract with Research Councils UK (RCUK) for the supply of synthetic oligonucleotides.
RCUK coordinates the UK’s seven research councils, enhancing the overall impact and effectiveness of the research they fund. As one of the preferred suppliers of custom oligonucleotides, IDT’s expert production technologies will aid RCUK in delivering on the UK government’s objectives for science and innovation.
Each year RCUK invests approximately £2.5 billion in research, covering a broad spectrum of academic disciplines from medical and biological sciences, to astronomy, physics and chemistry. “We are delighted to name IDT as one of our preferred suppliers of custom oligonucleotides” commented Richard Fowles, Category Manager, RCUK. He continued, “IDT’s advanced manufacturing capabilities will provide the scientists we fund with a broad range of synthetic oligos to cover all of their requirements.”
“It is fantastic news that we have been selected as a preferred supplier by RCUK. We want researchers in the UK to benefit from IDT’s twenty-year commitment to tireless innovation and peerless quality in oligo synthesis. We can also use this opportunity to learn how IDT can best support research worldwide, as the science and application of synthetic biology advances,” commented Dr. Joseph A. Walder, IDT’s founder and CEO.
RCUK coordinates the UK’s seven research councils, enhancing the overall impact and effectiveness of the research they fund. As one of the preferred suppliers of custom oligonucleotides, IDT’s expert production technologies will aid RCUK in delivering on the UK government’s objectives for science and innovation.
Each year RCUK invests approximately £2.5 billion in research, covering a broad spectrum of academic disciplines from medical and biological sciences, to astronomy, physics and chemistry. “We are delighted to name IDT as one of our preferred suppliers of custom oligonucleotides” commented Richard Fowles, Category Manager, RCUK. He continued, “IDT’s advanced manufacturing capabilities will provide the scientists we fund with a broad range of synthetic oligos to cover all of their requirements.”
“It is fantastic news that we have been selected as a preferred supplier by RCUK. We want researchers in the UK to benefit from IDT’s twenty-year commitment to tireless innovation and peerless quality in oligo synthesis. We can also use this opportunity to learn how IDT can best support research worldwide, as the science and application of synthetic biology advances,” commented Dr. Joseph A. Walder, IDT’s founder and CEO.
